Yu Ko

发表

Reasons provided by prescribers when overriding drug-drug interaction alerts.

Donna C. Dare, John E. Murphy, D. Malone, 2007, The American journal of managed care.

Potential drug-drug interactions within Veterans Affairs medical centers.

John E. Murphy, D. Malone, J. Abarca, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.

K. Yap, Yu Ko, A. Chan, 2009, Clinical therapeutics.

A National Survey on Prescribers' Knowledge of and Their Source of Drug-Drug Interaction Information-An Application of Item Response Theory

Yu Ko, 2007 .

Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore.

F. Xie, Yu Ko, A. Chan, 2012, Value in health regional issues.

Potential determinants of prescribers' drug-drug interaction knowledge.

D. Malone, E. Armstrong, G. Skrepnek, 2008, Research in social & administrative pharmacy : RSAP.

Patient Needs and Sources of Drug Information in Singapore: Is the Internet Replacing Former Sources?

Yu Ko, C. Ho, Mui-Ling Tan, 2009, The Annals of pharmacotherapy.

Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control.

H. Ng, Yu Ko, M. Kong, 2014, Thrombosis research.

Utility evaluation of health states related to stroke and stroke prophylaxis

Yu Ko, M. Kong, Y. Wang, 2013 .

Health and economic burden of HPV-related diseases in Singapore.

A. Ilancheran, Yu Ko, J. Low, 2012, Asian Pacific journal of cancer prevention : APJCP.

Clinically Significant Drug–Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia

Yu Ko, A. Chan, C. Wong, 2008, The Annals of pharmacotherapy.

Pharmacoeconomic Evaluation of Antimuscarinic Agents for the Treatment of Overactive Bladder

D. Malone, E. Armstrong, Yu Ko, 2006, Pharmacotherapy.

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

H. Ng, F. Xie, Yu Ko, 2014, Cardiovascular Drugs and Therapy.

Identification and Evaluation of Pharmacists' Commonly Used Drug Information Sources

G. Sklar, Yu Ko, Yu Ko, 2009, The Annals of pharmacotherapy.

Health State Utility Assessment for Breast Cancer.

F. Xie, Yu Ko, A. Chan, 2012, Value in health regional issues.

Research Paper: Practitioners' Views on Computerized Drug-Drug Interaction Alerts in the VA System

W. Paul Nichol, Daniel C. Malone, Yu Ko, 2007, J. Am. Medical Informatics Assoc..

Patient-reported health preferences of anticoagulant-related outcomes

H. Ng, F. Xie, Yu Ko, 2015, Journal of Thrombosis and Thrombolysis.

Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.

Agus Salim, W. Yong, Yu Ko, 2012, Clinical therapeutics.

Diagramming patients' views of root causes of adverse drug events in ambulatory care: an online tool for planning education and research.

Yu Ko, R. Woosley, Mary Brown, 2006, Patient education and counseling.

Clinical impact of drug-drug interaction between aspirin and prednisolone at a cancer center.

Agus Salim, W. Yong, Yu Ko, 2012, Clinical therapeutics.

Stigma and health-related quality of life in Asian adults with epilepsy

S. Chan, Yu Ko, Y. Lim, 2009, Epilepsy Research.

Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin

Yu Ko, M. Kong, Ye Wang, 2012, Thrombosis and Haemostasis.

Assessment of Preference for Hormonal Treatment-Related Health States among Patients with Breast Cancer.

F. Xie, Yu Ko, X. Tan, 2014, Value in health regional issues.

Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients

Yu Ko, A. Chan, J. Chiang, 2014, Supportive Care in Cancer.

Costs and length of stay of drug-related hospital admissions in cancer patients.

Yu Ko, A. Chan, J. Chiang, 2014, Clinical therapeutics.

Identification and physicians’ views of their commonly-used drug information sources in Singapore

G. Sklar, Yu Ko, H. Lua, 2011, International Journal of Clinical Pharmacy.

Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan

Yu Ko, J. Hsu, S. Chiang, 2021, Healthcare.

Comparison of three medication adherence measures in patients taking warfarin

Yu Ko, M. Kong, Ye Wang, 2013, Journal of Thrombosis and Thrombolysis.

PRM26 Comparison of Three Medication Adherence Measures in Patients Taking Warfarin

Yu Ko, M. Kong, Ye Wang, 2012 .

Prescribers’ Knowledge of and Sources of Information for Potential Drug-Drug Interactions

Daniel C Malone, Raymond L Woosley, Jacob Abarca, 2008, Drug safety.

Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore.

F. Xie, Yu Ko, A. Chan, 2012, Value in health regional issues.

Assessment of Preference for Hormonal Treatment-Related Health States among Patients with Breast Cancer.

F. Xie, Yu Ko, X. Tan, 2014, Value in health regional issues.